公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2013 | Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study | CHIH-HUNG HSU ; Kang Y.K.; Yang T.-S.; CHIA-TUNG SHUN ; YU-YUN SHAO ; Su W.-C.; Sandoval-Tan J.; Chiou T.-J.; Jin K.; CHIUN HSU ; ANN-LII CHENG | Oncology (Switzerland) | 40 | 41 | |
2016 | Characteristics of Taiwanese patients of PNH in the international PNH registry | WEN-CHIEN CHOU ; Huang W.-H.; Wang M.-C.; Chang C.-S.; Yeh S.-P.; Chiou T.-J.; Chen Y.-C.; Lin T.-H.; MING-CHING SHEN ; on behalf of the Taiwan PNH study group | Thrombosis Journal | 5 | 0 | |
1991 | Clonality and clonal evolution of hepatocellular carcinoma with multiple nodules | Hsu H.-C.; Chiou T.-J.; Chen J.-Y.; Lee C.-S.; PO-HUANG LEE ; Peng S.-Y. | Hepatology | 113 | 110 | |
2019 | Comparative study on baseline clinical characteristics of Asian versus non-Asian patients with paroxysmal nocturnal hemoglobinuria | Sakurai M.; Jang J.H.; WEN-CHIEN CHOU ; Kim J.S.; Wilson A.; Nishimura J.-I.; Chiou T.-J.; Kanakura Y.; Lee J.W.; Okamoto S. | International Journal of Hematology | 9 | 8 | |
1988 | Evolution of expression of hepatitis B surface and core antigens (HBsAg, HBcAg) in resected primary and recurrent hepatocellular carcinoma in HBsAg carriers in Taiwan. Correlation with local host immune response | Hsu H.-C.; Wu T.-T.; MU-ZON WU ; Wu C.-Y.; Chiou T.-J.; JIN-CHUAN SHEU ; Lee C.-S.; DING-SHINN CHEN | Cancer | 16 | ||
2014 | Guidelines for treating iron overload in myelodysplastic syndromes: A Taiwan consensus statement | BOR-SHENG KO ; Chang C.-S.; Chang M.-C.; Chen T.Y.; Chiou T.-J.; Chiu C.-F.; Huang W.-L.; Kao W.-Y.; Lan Y.-J.; Lin S.-F.; Tan T.-D.; JIH-LUH TANG ; Tzeng C.-H.; Wang P.-N.; Yet S.-P.; HWEI-FANG TIEN | International Journal of Hematology | 8 | 6 | |
2019 | Long-term safety and efficacy of deferasirox in patients with myelodysplastic syndrome, aplastic anemia and other rare anemia in Taiwan | BOR-SHENG KO ; Chang M.-C.; Chiou T.-J.; Chang T.-K.; Chen Y.-C.; Lin S.-F.; Chang C.-S.; Lu Y.-C.; Yeh S.-P.; Chen T.-Y.; Hwang W.-S. | Hematology (United Kingdom) | 5 | 4 | |
2012 | A nation-wide analysis of venous thromboembolism in 497,180 cancer patients with the development and validation of a risk-stratification scoring system | Yu Y.-B.; Gau J.-P.; Liu C.-Y.; Yang M.-H.; Chiang S.-C.; Hsu H.-C.; Hong Y.-C.; Hsiao L.-T.; Liu J.-H.; Chiou T.-J.; Chen P.-M.; TZONG-SHYUAN LEE ; Chou L.-F.; Tzeng C.-H.; Chen T.-J. | Thrombosis and Haemostasis | 89 | 89 | |
2020 | A nationwide survey of fatigue in cancer patients in Taiwan: An unmet need | Rau K.-M.; Rau K.-M.; SHIOW-CHING SHUN ; Chiou T.-J.; Lu C.-H.; Lu C.-H.; Ko W.-H.; Ko W.-H.; Lee M.-Y.; Huang W.-T.; KUN-HUEI YEH ; Chang C.-S.; Chang C.-S.; Hsieh R.-K. | Japanese Journal of Clinical Oncology | 9 | 9 | |
2015 | Pharmacokinetic profile and first preliminary clinical evaluation of bendamustine in Taiwanese patients with heavily pretreated indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma | Hsiao L.-T.; HWEI-FANG TIEN ; Kuo C.-Y.; Wu J.-H.; HSIN-AN HOU ; Wang M.-C.; Liu C.-Y.; Chen P.-M.; Chiou T.-J. | Hematological Oncology | 1 | 1 | |
2011 | A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan | Chen J.-S.; Chao Y.; Hsieh R.-K.; ANN-LII CHENG ; Chen P.-M.; Chiou T.-J.; Chao T.-Y.; KUN-HUEI YEH ; Chen L.-T.; Whang-Peng J. | Cancer Chemotherapy and Pharmacology | 6 | 5 | |
2007 | Randomized phase II trial of thalidomide alone versus thalidomide plus interferon alpha in patients with refractory multiple myeloma | Chiou T.-J.; Wang T.-H.; Chao T.-Y.; Lin S.-F.; JIH-LUH TANG ; Chen T.-Y.; Chang M.-C.; Hsueh E.-J.; Chen P.-M. | Cancer Investigation | 14 | 10 | |
1997 | Weekly CAF chemotherapy for advanced breast cancer patients | Hwang W.-S.; Hsiung C.A.; Ko W.-S.; lVang C.-C.; Chang J.-V.; Lai G.-M.; Hsieh R.-K.; Tsao C.-J.; Chen L.-T.; Law C.-K.; ANN-LII CHENG ; Fan S.F.; Tzeng C.-H.; Chiou T.-J.; Whang-Peng J. | Oncology (Switzerland) | 1 | 1 |